Target intelligence / Profile preview

Immunoglobulin heavy variable 3-7 (IGHV3-7)

Target
IGHV3-7
Molecular classification
Other (immunoglobulin gene segment)
01

Overview

Immunoglobulin heavy variable 3-7 (IGHV3-7) is a gene segment encoding the variable (V) region of the heavy chain of immunoglobulins (antibodies)[1][4][5]. This V region participates in the formation of the antigen-binding site of the antibody by combining with diversity (D) and joining (J) gene segments through a DNA rearrangement process specific to B cell development[2]. The protein product is part of the variable domain of the immunoglobulin heavy chain, critical for recognizing and binding specific antigens[1][5]. Membrane-bound immunoglobulin molecules function as B cell receptors, while secreted forms mediate antigen elimination as antibodies[2]. IGHV3-7 itself is not a drug target, but rather one of many gene segments contributing to antibody diversity[1][5]. Changes in IGHV3-7 sequence or usage can reflect or contribute to immune repertoire diversity and have indirect associations with immune disorders, but it is not considered a standalone receptor or therapeutic target[1][4][5][2].

Other names
Immunoglobulin heavy variable 3-7IGHV3-7Ig heavy chain V-III region GALIg heavy chain V-III region GARIg heavy chain V-III region JONIGHV37VHimmunoglobulin heavy chain variable region
02

Biological functions

Antigen recognitionImmune response (specifically, humoral immunity)
03

Disease associations

Other (no direct implication in disease as a therapeutic target, but may be indirectly associated with immunological conditions, B cell malignancies, or immune repertoire changes)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-7 (IGHV3-7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-7 (IGHV3-7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call